Abstract 5815
Background
Compared with the classical tumor markers, ctDNA has higher accuracy and specificity while being noninvasive. Based on the prophase work, we explore the role of ctDNA methylation in the detection of PCDH18 as a new tumor marker compared with CEA in the clinical diagnosis and progressive evaluation of colorectal cancer (CRC).
Methods
We collected peripheral blood from 60 patients with advanced primary CRC before and after two courses of treatment, as well as from 60 healthy individuals, and the clinicopathologic characteristics were analyzed. The changes of CEA levels before and after treatment were dynamically monitored by electrochemiluminescence (ECL). The methylation status of PCDH18 was detected by qMSP, the correlation between them was also statistically analyzed, and the value of different indexes in the diagnosis and monitoring of tumor progression of CRC were compared.
Results
We found that the percentage of methylation of PCDH18 in plasma of CRC before treatment was significantly higher than that of normal plasma samples. The difference (p < 0.01) suggests that PCDH18 methylation may be involved in the carcinogenesis of CRC. PCDH18 methylation was not significantly correlated with sex, tumor location, histological type, tumor differentiation, TNM or CEA(P > 0.05). To further explore the relationship between the methylation of PCDH18 and the risk of CRC, the results showed that with the increase of methylation level of PCDH18, the risk of CRC and tumor progression increased significantly, while in CEA group, the OR > 1 only in the group with CEA elevation as the dividing point, but the P value was not statistically significant. The sensitivity and specificity of PCDH18 ctDNA methylation combined with CEA in the diagnosis of progression of CRC were 90.0% and 67.6%, respectively. The area under the curve (AUC) reached 0.861. Further analysis showed that PCDH18 ctDNA methylation was 67.86% while CEA was negative in CRC progression patients, indicating that PCDH18 ctDNA methylation could significantly increase the detection of progression in comparison with CEA.
Conclusions
The methylation of PCDH18 ctDNA may play an important role in the diagnosis and prediction of tumor progression in CRC as a new tumor marker and can significantly increase the detection of tumor progression in CEA-negative patients. W-W. Tang, H-X. An and D. Zhou contributed equally to this work.
Clinical trial identification
Legal entity responsible for the study
Clinical research Ethics Committee of the First Affiliated Hospital of Xiamen University.
Funding
This study was supported by the National Natural Science Foundation of China (No. 81702414), the Fujian Provincial Health and Family Planning Commission Foundation of Youth scientific research project (No. 2015-2-43) and Xiamen Science and Technology Bureau Foundation of science and technology project for the benefit of the people (No. 3502Z20164010).
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract